Literature DB >> 19512957

Codeine and morphine pathway.

Caroline F Thorn1, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19512957     DOI： 10.1097/FPC.0b013e32832e0eac

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  22 in total

1.  Pharmacogenetic testing: Current Evidence of Clinical Utility.

Authors:  Jivan Moaddeb; Susanne B Haga
Journal:  Ther Adv Drug Saf       Date:  2013-08-01

2.  ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children.

Authors:  Raja Venkatasubramanian; Tsuyoshi Fukuda; Jing Niu; Tomoyuki Mizuno; Vidya Chidambaran; Alexander A Vinks; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2014-07       Impact factor: 2.533

3.  [Interaction of opioid analgesics at the level of biotransformation].

Authors:  H Petri; D Grandt
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

4.  Long-term tracking of opioid consumption in two United States cities using wastewater-based epidemiology approach.

Authors:  Adam J Gushgari; Arjun K Venkatesan; Jing Chen; Joshua C Steele; Rolf U Halden
Journal:  Water Res       Date:  2019-06-03       Impact factor: 11.236

5.  A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events.

Authors:  M E Moretti; D F Lato; H Berger; G Koren; S Ito; W J Ungar
Journal:  Pharmacogenomics J       Date:  2017-07-11       Impact factor: 3.550

6.  The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects.

Authors:  Xiujun Wu; Li Yuan; Jinliang Zuo; Jing Lv; Tao Guo
Journal:  Eur J Clin Pharmacol       Date:  2014-01       Impact factor: 2.953

7.  PharmGKB: the Pharmacogenomics Knowledge Base.

Authors:  Caroline F Thorn; Teri E Klein; Russ B Altman
Journal:  Methods Mol Biol       Date:  2013

8.  Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.

Authors:  Roseann S Gammal; Kristine R Crews; Cyrine E Haidar; James M Hoffman; Donald K Baker; Patricia J Barker; Jeremie H Estepp; Deqing Pei; Ulrich Broeckel; Winfred Wang; Mitchell J Weiss; Mary V Relling; Jane Hankins
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

9.  Pharmacogenetics: Using Genetic Information to Guide Drug Therapy.

Authors:  Ku-Lang Chang; Kristin Weitzel; Siegfried Schmidt
Journal:  Am Fam Physician       Date:  2015-10-01       Impact factor: 3.292

10.  Neonatal withdrawal syndrome due to maternal codeine use.

Authors:  Vrinda Nair; Amuchou Singh Soraisham; Albert Akierman
Journal:  Paediatr Child Health       Date:  2012-05       Impact factor: 2.253
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.